Samsung Biologics | search
Click here to view Samsung Biologics news from 60+ newspapers.
Bookmark or Share- Newsroom | Samsung Biologics | The Leading Global CDMO with End-to-End ...Latest News. View All. Press Releases Apr 24, 2024. Samsung Biologics Reports First Quarter 2024 Financial Results. Media Focus Apr 19, 2024. Why JPMorgan, Deloitte, Meta & More Support Record SAF Deal. Media Focus Apr 11, 2024. Benefiting from single-use tech downstream. News Brief Mar 21, 2024.
- Samsung Biologics | The Leading Global CDMO with End-to-End ServicesSamsung Biologics is a fully integrated CDMO with qualified and highly innovative contract development, contract manufacturing, and biosafety testing services.
- Samsung Biologics - Wikipediawww .samsungbiologics .com. Samsung Biologics is a South Korean biotechnology company headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, it provides contract development and manufacturing (CDMO) services to the biopharmaceutical industry.
- Our DNA | Company | About Us | SAMSUNG BIOLOGICSSamsung Biologics is a fully integrated, end-to-end CDMO service provider offering seamless development and manufacturing solutions from cell line development to final aseptic fill/finish as well as laboratory testing services at every stage for biopharmaceutical products.
- Samsung Biologics Reports First Quarter 2024 Financial ResultsAbout Samsung Biologics Co., Ltd. Samsung Biologics (KRX: 207940.KS) is a fully integrated, end-to-end CDMO service provider, offering seamless development and manufacturing solutions from cell line development to final aseptic fill/finish as well as laboratory testing support for the biopharmaceutical products we manufacture.
More
